Formation Bio Secures $372 Million Series D Funding to Propel AI-Driven Drug Development
Formation Bio, a pioneering force at the intersection of technology and pharmaceuticals, has announced a landmark achievement with the closure of a $372 million Series D financing round. This funding round was led by prominent investors including a16z and Sanofi, with continued support from existing backers such as Sequoia, Thrive, Emerson Collective, and Lachy Groom,…